...
首页> 外文期刊>Journal of Medicinal Chemistry >Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B
【24h】

Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B

机译:亮氨酸的选择性,共晶结构和神经保护特性,亮氨酸是一种来自海洋海绵生物碱亮翠胺B的蛋白激酶抑制剂家族

获取原文
获取原文并翻译 | 示例
           

摘要

DYRKs (dual specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) are implicated in the onset and development of Alzheimers disease and Down syndrome. The marine sponge alkaloid leucettamine B was recently identified as an inhibitor of DYRKs/CLKs. Synthesis of analogues (leucettines) led to an optimized product, leucettine L41. Leucettines were cocrystallized with DYRK1A, DYRK2, CLK3, PIM1, and GSK-3β. The selectivity of L41 was studied by activity and interaction assays of recombinant kinases and affinity chromatography and competition affinity assays. These approaches revealed unexpected potential secondary targets such as CK2, SLK, and the lipid kinase PIKfyve/Vac14/Fig4. L41 displayed neuroprotective effects on glutamate-induced HT22 cell death. L41 also reduced amyloid precursor protein-induced cell death in cultured rat brain slices. The unusual multitarget selectivity of leucettines may account for their neuroprotective effects. This family of kinase inhibitors deserves further optimization as potential therapeutics against neurodegenerative diseases such as Alzheimers disease.
机译:DYRKs(双重特异性,酪氨酸磷酸化调节激酶)和CLKs(cdc2样激酶)与阿尔茨海默氏病和唐氏综合症的发生和发展有关。最近鉴定出海洋海绵生物碱亮氨酰胺B是DYRKs / CLKs的抑制剂。合成类似物(亮氨酸)可以得到优化的产品,leucettine L41。亮氨酸与DYRK1A,DYRK2,CLK3,PIM1和GSK-3β共结晶。通过重组激酶的活性和相互作用测定,亲和层析和竞争亲和测定来研究L41的选择性。这些方法揭示了出乎意料的潜在二级目标,例如CK2,SLK和脂质激酶PIKfyve / Vac14 / Fig4。 L41对谷氨酸诱导的HT22细胞死亡显示出神经保护作用。 L41还减少了培养的大鼠脑切片中淀粉样蛋白前体蛋白诱导的细胞死亡。亮氨酸的不同寻常的多靶点选择性可能是其神经保护作用的原因。该激酶抑制剂家族作为针对神经退行性疾病例如阿尔茨海默氏病的潜在治疗剂值得进一步优化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号